Kathy M. Ceballos

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screening.

Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screening.

Journal: International journal of cancer

Published: November 08, 2018

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.

Journal: JAMA

Published: July 05, 2018

Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial.

Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Published: May 31, 2018

Post-Loop Electrosurgical Excision Procedure High-Risk Human Papillomavirus Testing as a Test of Cure: The British Columbia Experience.

Post-Loop Electrosurgical Excision Procedure High-Risk Human Papillomavirus Testing as a Test of Cure: The British Columbia Experience.

Journal: Journal of lower genital tract disease

Published: September 28, 2017

Aptima HPV Assay versus Hybrid Capture® 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial.

Aptima HPV Assay versus Hybrid Capture® 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Published: August 03, 2016

Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial.

Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial.

Journal: British journal of cancer

Published: June 17, 2016

HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.

HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.

Journal: International journal of cancer

Published: April 12, 2016

BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer.

BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 07, 2016

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial.

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial.

Journal: BMC cancer

Published: July 24, 2015

Interobserver agreement for assessing invasion in stage 1A vulvar squamous cell carcinoma.

Interobserver agreement for assessing invasion in stage 1A vulvar squamous cell carcinoma.

Journal: The American journal of surgical pathology

Published: October 01, 2013

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study.

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study.

Journal: British journal of cancer

Published: November 22, 2012

Tissue microarray for routine clinical breast biomarker analysis. The British Columbia Cancer Agency 2008 experience.

Tissue microarray for routine clinical breast biomarker analysis. The British Columbia Cancer Agency 2008 experience.

Journal: American journal of clinical pathology

Published: May 18, 2010

Showing 1-12 of 19

Last Updated: 09/26/2026